Synthesis of Apoptosis-Inducing Agents via Crystalline Intermediates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Previous processes for synthesizing Bcl-2 inhibitors, such as Compound 1 and Compound 2, face challenges in scalability, yield, and purification complexity, making them impractical for commercial production and clinical development.
Innovation Solution
A novel process involving a selective nucleophilic aromatic substitution reaction (SnAr reaction) with milder conditions and shorter reaction times, utilizing crystalline intermediates for efficient purification, and a convergent cross-coupling reaction to enhance yield and simplify the synthesis of these compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If previous synthesis processes are used for Bcl-2 inhibitors, then the compounds can be produced, but the overall yield is low and purification is complex
Solution Approach 1:
The patent changes the reaction parameters by using a two-stage synthesis approach with specific reagents and conditions. Stage 1 uses NaH and DMF at controlled temperatures to form the intermediate, while Stage 2 uses EDCI and HOBt in DCM to complete the coupling. These parameter changes result in improved yields (Stage 1: 85-95%, Stage 2: 90-98%) and simplified purification compared to previous processes
Solution Approach 2:
The synthesis process is segmented into two distinct stages with isolated purification steps. Stage 1 produces a crystalline intermediate that can be purified independently, and Stage 2 completes the synthesis from this purified intermediate. This segmentation allows each stage to be optimized independently and simplifies the overall purification process by removing impurities at the intermediate stage
2Speed
If previous synthesis processes are used, then compounds can be synthesized, but the reaction conditions are harsh and reaction times are long
Solution Approach 1:
The patent introduces crystalline intermediates as mediators between the starting materials and final products. The intermediate formed in Stage 1 serves as a stable, isolable compound that facilitates the overall transformation under milder conditions. This intermediary approach allows for better control of reaction conditions and reduces the need for harsh reagents and extended reaction times
Solution Approach 2:
The first stage of the synthesis performs a preliminary transformation to create a functionalized intermediate with the desired core structure. This preliminary action prepares the molecule for the final coupling step, allowing the overall synthesis to proceed under milder conditions in the second stage rather than requiring harsh conditions throughout the entire process
3Ease of manufacture
If previous processes are used, then synthesis can be performed, but scalability is limited and the process is impractical for commercial production
Solution Approach 1:
The patent modifies the synthesis parameters to enable scale-up by using reagents and conditions that are easier to control in large-scale operations. The two-stage process with isolated purification steps allows for better control of reaction parameters at scale, and the high yields at each stage ensure economical production. The crystalline intermediate facilitates filtration and purification operations that are more easily scaled than previous methods
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The improved process increases the overall yield and efficiency of Compound 1 and Compound 2 production, making them viable for commercial and clinical applications by simplifying the synthesis and reducing the need for tedious purification steps.
Implementation Method 1
A novel process involving a selective nucleophilic aromatic substitution reaction (SnAr reaction) with milder conditions and shorter reaction times
Implementation Method 2
a convergent cross-coupling reaction to enhance yield and simplify the synthesis of these compounds
Data Source
AI summary
Provided herein is a process for the preparation of an apoptosis-inducing agent, and chemical intermediates thereof. Also provided herein are novel chemical intermediates related to the process provided herein.